Why this pharma stock hit nearly 9-year high; froze at 10% upper circuit?

Quick Summary:

Wockhardt stock gained 10% to touch Rs 1,536.

Home / Markets / News / Why this pharma stock hit nearly 9-year high; froze at 10% upper circuit?

ICRA also notes that the company has partnered with Serum Institute of India (Serum), to manufacture vaccines at the company’s manufacturing facility in the UK and revenues from the same are expected to commence from FY2026.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Tata Mutual Fund Bandhan Mutual Fund Pharma stock Chemotherapy Pharma stock in focus Cancer Zaynich ICRA HDFC Mutual Fund Wochkardt shares Pharma stock list QIP Antibiotic Qualified institutional placement Liver transplant Biotech

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-16 @ 11:05:59 (17 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 704 words

Reading Time: 4 minutes read

Sentences: 29 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 24426299

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 325 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions